267 related articles for article (PubMed ID: 32833726)
1. SARS-CoV-2-Associated Guillain-Barre Syndrome With Good Response to Plasmapheresis.
Granger A; Omari M; Jakubowska-Sadowska K; Boffa M; Zakin E
J Clin Neuromuscul Dis; 2020 Sep; 22(1):58-59. PubMed ID: 32833726
[No Abstract] [Full Text] [Related]
2. Guillain-Barré syndrome after covid-19 infection.
García-Manzanedo S; López de la Oliva Calvo L; Ruiz Álvarez L
Med Clin (Barc); 2020 Oct; 155(8):366. PubMed ID: 32718718
[No Abstract] [Full Text] [Related]
3. Guillain-Barré Syndrome in a Patient With Evidence of Recent SARS-CoV-2 Infection.
Naddaf E; Laughlin RS; Klein CJ; Toledano M; Theel ES; Binnicker MJ; Nagappan V; Abdulrazzak M; Phelan DM
Mayo Clin Proc; 2020 Aug; 95(8):1799-1801. PubMed ID: 32753154
[No Abstract] [Full Text] [Related]
4. Guillain-Barré syndrome related to COVID-19 infection.
Alberti P; Beretta S; Piatti M; Karantzoulis A; Piatti ML; Santoro P; Viganò M; Giovannelli G; Pirro F; Montisano DA; Appollonio I; Ferrarese C
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32350026
[No Abstract] [Full Text] [Related]
5. Novel Coronavirus (COVID-19)-Associated Guillain-Barré Syndrome: Case Report.
Rana S; Lima AA; Chandra R; Valeriano J; Desai T; Freiberg W; Small G
J Clin Neuromuscul Dis; 2020 Jun; 21(4):240-242. PubMed ID: 32453100
[No Abstract] [Full Text] [Related]
6. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
[TBL] [Abstract][Full Text] [Related]
7. Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2.
Bracaglia M; Naldi I; Govoni A; Brillanti Ventura D; De Massis P
J Neurol; 2020 Nov; 267(11):3166-3168. PubMed ID: 32588185
[No Abstract] [Full Text] [Related]
8. Post SARS-CoV-2 Guillain-Barré syndrome.
Arnaud S; Budowski C; Ng Wing Tin S; Degos B
Clin Neurophysiol; 2020 Jul; 131(7):1652-1654. PubMed ID: 32422529
[No Abstract] [Full Text] [Related]
9. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
[TBL] [Abstract][Full Text] [Related]
10. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
Agha Abbaslou M; Karbasi M; Mozhdehipanah H
Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
Uncini A; Vallat JM; Jacobs BC
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
[TBL] [Abstract][Full Text] [Related]
12. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
Abrams RMC; Kim BD; Markantone DM; Reilly K; Paniz-Mondolfi AE; Gitman MR; Choo SY; Tse W; Robinson-Papp J
J Neurovirol; 2020 Oct; 26(5):797-799. PubMed ID: 32720233
[TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré Syndrome Associated with SARS-CoV-2.
Toscano G; Palmerini F; Ravaglia S; Ruiz L; Invernizzi P; Cuzzoni MG; Franciotta D; Baldanti F; Daturi R; Postorino P; Cavallini A; Micieli G
N Engl J Med; 2020 Jun; 382(26):2574-2576. PubMed ID: 32302082
[No Abstract] [Full Text] [Related]
14. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection.
Coen M; Jeanson G; Culebras Almeida LA; Hübers A; Stierlin F; Najjar I; Ongaro M; Moulin K; Makrygianni M; Leemann B; Kronig I; Bertrand J; Reny JL; Schibler M; Serratrice J
Brain Behav Immun; 2020 Jul; 87():111-112. PubMed ID: 32360440
[No Abstract] [Full Text] [Related]
15. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection.
Chan JL; Ebadi H; Sarna JR
Can J Neurol Sci; 2020 Nov; 47(6):852-854. PubMed ID: 32468972
[No Abstract] [Full Text] [Related]
17. Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
Diez-Porras L; Vergés E; Gil F; Vidal MJ; Massons J; Arboix A
Neuromuscul Disord; 2020 Oct; 30(10):859-861. PubMed ID: 32912716
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
Sancho-Saldaña A; Lambea-Gil Á; Liesa JLC; Caballo MRB; Garay MH; Celada DR; Serrano-Ponz M
Clin Med (Lond); 2020 Jul; 20(4):e93-e94. PubMed ID: 32518103
[TBL] [Abstract][Full Text] [Related]
19. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2.
Marta-Enguita J; Rubio-Baines I; Gastón-Zubimendi I
Neurologia (Engl Ed); 2020 May; 35(4):265-267. PubMed ID: 32364124
[No Abstract] [Full Text] [Related]
20. Guillain-Barré syndrome associated with SARS-CoV-2 infection.
Velayos Galán A; Del Saz Saucedo P; Peinado Postigo F; Botia Paniagua E
Neurologia (Engl Ed); 2020 May; 35(4):268-269. PubMed ID: 32364123
[No Abstract] [Full Text] [Related]
[Next] [New Search]
